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Probiotic microorganisms are incorporated into a wide variety of foods, supplements,
and pharmaceuticals to promote human health and wellness. However, maintaining
bacterial cell viability during storage and gastrointestinal transit remains a challenge.
Encapsulation of bifidobacteria within food-grade hydrogel particles potentially mitigates
their sensitivity to environmental stresses. In this study, Bifidobacterium longum
subspecies and strains were encapsulated in core-shell microgels consisting of an
alginate core and a microgel shell. Encapsulated obligate anaerobes Bifidobacterium
longum subsp. infantis and Bifidobacterium longum subsp. longum exhibited differences
in viability in a strain-dependent manner, without a discernable relationship to
subspecies lineage. This includes viability under aerobic storage conditions and
modeled gastrointestinal tract conditions. Coating alginate microgels with chitosan
did not improve viability compared to cells encapsulated in alginate microgels alone,
suggesting that modifying the surface charge alone does not enhance delivery.
Thus hydrogel beads have great potential for improving the stability and efficacy of
bifidobacterial probiotics in various nutritional interventions.
Keywords: microencapsulation, bifidobacteria, probiotics, simulated digestion, oral delivery
INTRODUCTION
Beneficial bacteria are often incorporated into functional foods and nutritional interventions to be
ingested orally as probiotics. This includes humans and livestock animals that receive direct-fed
microbials to enhance health outcomes and reduce pathogen load (Braat et al., 2006; Puccio et al.,
2007; Neal-McKinney et al., 2012; Watson and Preedy, 2015). Bifidobacterium longum colonizes
the human gastrointestinal tract (GIT) and is one of the 48 recognized taxa that are encompassed
within the genus Bifidobacterium (Milani et al., 2014; Sun et al., 2015). This obligate anaerobe is
one of the earliest colonizers of the infant GIT, and is present in lower concentrations in the adult
gut (Schell et al., 2002; Sela et al., 2008). The bifidobacterial taxa longum, infantis, and suis were
previously classified as discrete species, but more recently they were reclassified as subspecies of
B. longum (Sakata et al., 2002). Their unification as a single species is based primarily on genomic
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and phenotypic similarities shared between these groups. While
Bifidobacterium animalis subsp. lactis is often used for probiotic
applications, B. longum strains are of particular interest due to
its likely co-evolution with humans. This is evident in B. longum
utilization of human milk oligosaccharides and establishes a
protective gut microbiome in infants through adulthood (Sela
and Mills, 2010).
Bifidobacterium longum is deployed in several probiotic
applications using a variety of delivery formats (Adhikari et al.,
2000; Fortin et al., 2011; Amine et al., 2014; Lewis et al.,
2015). A relatively large dose of probiotics is recommended
to impart health benefits, typically 106–107 CFU/g per day
(Krasaekoopt et al., 2003; Roy, 2005). However, the direct
incorporation of free probiotic cells into food products and
supplements results in a significant decrease in cell viability
throughout storage and gastrointestinal transit (Sultana et al.,
2000; de Vos et al., 2010). Therefore, prolonged storage and
the process of ingesting these probiotics may reduce their
viability below recommended levels to achieve health benefits.
Microencapsulating probiotic cells within hydrogel matrices
protects them against extrinsic environmental factors thereby
enhancing bacterial survival during processing, storage, and
digestion (de Vos et al., 2010; Fareez et al., 2015; Yeung et al.,
2016). Encapsulation may also dictate the controlled release of the
probiotic at the precise anatomical site of activity within the GIT,
thereby enhancing the efficacy of the probiotic through specific
targeting after oral delivery (de Barros et al., 2015; Zhang et al.,
2015b).
Several biopolymer materials are available to encapsulate
microbes in hydrogel matrices, depending on the desired
physicochemical properties of the delivery vehicle. The most
commonly used food-grade biopolymers are proteins (e.g.,
whey proteins and caseins) and carbohydrates (e.g., starch and
gums; Bagchi et al., 2010; Gaonkar et al., 2014; Etchepare
et al., 2015). For many food applications, it is advantageous to
encapsulate probiotics within hydrogel beads that trap bacteria
within small particles containing cross-linked biopolymer
molecules. These microgels must be engineered to encapsulate
high concentrations of probiotics and protect them from
environmental stresses, such as acidic pH, bile salts, and
digestive enzymes (Zhang et al., 2015a). Alginate has been
widely used as a biopolymer suitable for food applications
as it is relatively inexpensive, easy to gel, biodegradable, and
compatible with many food systems (Gombotz and Wee, 2012;
Lee and Mooney, 2012). Indeed, recently studies have shown
that lactococcal-based probiotics can be encapsulated within
alginate microgels to improve their stability (Yeung et al.,
2016).
There are appreciable differences between probiotic strain
tolerance toward environmental and gastrointestinal stresses.
Consequently, it is possible to identify particular strains
that are more resistant to these stresses than others, which
are therefore more suitable for commercial application
(Godward et al., 2000; Krasaekoopt et al., 2004; Capela
et al., 2006). As an anaerobe, bifidobacterial species including
B. longum differ in their sensitivity to oxygen exposure and
other environmental stresses during the preparative phase
prior to probiotic deployment (Kawasaki et al., 2006; Ruiz
et al., 2012). Therefore, bifidobacterial probiotics may be
encapsulated to restrict oxidative damage during preparation
and storage and to limit exposure to degradative processes within
the GIT.
The aim of this study was to design, fabricate, and characterize
a food-grade encapsulation system to protect B. longum cells
during simulated storage and gastrointestinal passage. Previously,
we demonstrated that encapsulation of probiotics within alginate
microgels could improve their viability during storage (Yeung
et al., 2016). In the current study, we encapsulated B. longum
cells within alginate beads to determine if their viability could be
enhanced in storage and gastrointestinal transit. Moreover, the
impact of coating these alginate beads with a layer of chitosan
was investigated as well. Chitosan coated alginate beads have
previously been used to enhance the mucoadhesive properties of
probiotic bacteria (Chen et al., 2013).
MATERIALS AND METHODS
Preparation of Bacterial Cultures
Four strains of both Bifidobacterium longum subsp. longum
(B. longum) and Bifidobacterium longum subsp. infantis
(B. infantis) were studied (Table 1). All strains were originally
isolated from infant feces. Stock solutions were maintained by
storing bacteria at −80◦C in deMann, Regosa, Sharpe (MRS)
media with 0.05% L-cysteine in 25% glycerol. Bacteria were
propagated in MRS with L-cysteine at 37◦C for 24 h, checked for
purity, and maintained on MRS agar anaerobically. Anaerobic
conditions were maintained in a double chamber anaerobic
hood with an airlock (88% N2, 10% CO2, and 2% H2) from Coy
Laboratory Products (Grass Lake, Mississippi, USA).
Isolated colonies were routinely propagated in MRS broth
(50 mL) for 40 h at 37◦ C. Cells were harvested by centrifugation
at 4000 × g for 10 min, washed twice with 0.85% NaCl
(physiological saline) solution (25 mL), and suspended in
0.85% NaCl (2 mL). The resulting cell suspensions were used
either directly for assessing survival of free cells (i.e., no
encapsulation) or subjected to encapsulation as described in
section “Microencapsulation of Bifidobacterial Cells.” Free cell
suspensions (2 mL) were stored in 0.85% NaCl solution (50 mL)
at 2–5◦C for up to 5 weeks to model long-term storage
conditions.
TABLE 1 | Bifidobacterium longum strains selected for encapsulation.
Subspecies Strain designation
infantis UMA 298
UMA 299
UMA 300
UMA 305
longum UMA 306
UMA 318
UMA 401
UMA 402
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General Chemicals Used in
Encapsulation and Modeled Digestion
For bacterial culture preparation, MRS broth was obtained
from Becton Dickinson and Company (Sparks, MD, USA).
Agar, L-cysteine hydrochloric acid, and sodium chloride (NaCl)
were purchased from Sigma–Aldrich (St. Louis, MO, USA).
Glycerol and sodium citrate dihydrate was purchased from Fisher
Scientific (Fair Lawn, NJ, USA).
For encapsulation experiments, sodium alginate (TICA-algin
HG 400 powder) was donated by TIC Gums (White Marsh,
ML, USA). Calcium chloride hexahydrate, chitosan (medium
molecular weight) was obtained from Sigma-Aldrich. Glacial
acetic acid was purchased from Fisher Scientific.
For simulated digestion, ammonium nitrate, bile extract
porcine, lipase from porcine pancreas type II, pepsin from
porcine gastric mucosa, porcine gastric mucin type II, potassium
chloride, potassium citrate, potassium phosphate, sodium DL-
lactate, sodium hydroxide (NaOH), and uric acid sodium salt
were also purchased from Sigma-Aldrich. Hydrochloric acid
(HCl), phosphate buffer saline (PBS), and urea were purchased
from Fisher Scientific.
Microencapsulation of Bifidobacterial
Cells
Bifidobacteria were encapsulated within alginate microgels using
an injection–gelation method (Whelehan and Marison, 2011;
Seiffert, 2013). Briefly, 1% (w/v) sodium alginate solution was
prepared, autoclaved, and then cooled to ambient temperature.
The sterile alginate solution (198 mL) was mixed with 2 mL of
∼109 CFU/mL probiotic organisms suspended in physiological
saline. The polymeric solution was agitated to uniformly
distribute cells throughout the mixture. The alginate beads were
prepared aseptically using an encapsulator (Büchi B-390 R©, Büchi
Labortechnik AG, Flawil, Switzerland) with a nozzle size of
120 µm, using the manufacturer’s standard operating conditions
(amplitude 3, frequency 800 Hz, electrode 800 V, pressure 250–
300 mbar). Aliquots of probiotic/alginate solution were injected
into 0.1 M calcium chloride solution (350 mL). After 1-h
gelation under agitation, the resulting calcium alginate beads
were collected by filtration, rinsed with sterile deionized water
(200 mL), and re-filtered. Microbeads (∼30 mL) were stored in
physiological saline solution (50 mL) at 4◦C for up to 4 weeks to
model long-term storage conditions. This process was repeated
for all eight strains of bifidobacteria.
Unfilled alginate beads were prepared identically but without
the addition of bacterial strains to the alginate solution. 1%
alginate solution (200 mL) was extruded into of 0.1 M CaCl2
(350 mL) solution under continuous agitation. The working
parameters (nozzle diameter, frequency, charge, and pressure),
filtering steps and storage conditions used were the same as those
for the preparation of filled alginate beads.
An aqueous chitosan solution (0.4% w/v) was prepared as
described previously by Zhou et al. (1998). Briefly, chitosan
(0.4 g) was dissolved in distilled water (90 mL) and glacial
acetic acid (0.8 mL). The pH was adjusted to 5.0–5.1 with
NaOH, and the total volume was adjusted to 100 mL. The
solution was autoclaved and filtered to remove undissolved
solids. Subsequently, the alginate beads were submerged in the
chitosan solution to provide a secondary coating by electrostatic
attraction of the cationic chitosan molecules to the surfaces of the
anionic alginate beads. The mixture was agitated for 1 h before
filtering and rinsing beads with sterile distilled water. Chitosan-
coated alginate beads were then stored and analyzed as described
in section “Alginate and Chitosan-coated Alginate Microbead
Characterization.”
Alginate and Chitosan-Coated Alginate
Microbead Characterization
Particle Size Distribution
The particle size distribution was determined by static light
scattering (Mastersizer S, Malvern Instruments, Worcestershire,
UK). Each sample (1–2 mL) was suspended in distilled water
(10 mL) and vortexed to avoid multiple scattering effects and
to ensure homogeneity prior to analysis. Volume-weighted (D
[4,3]) and surface-weighted (D [3,2]) mean particle diameters
were obtained for all samples.
Optical Microscopy Characterization
The overall appearance of alginate and chitosan-coated alginate
beads was characterized with an optical microscope (C1 Digital
Eclipse, Nikon, Tokyo, Japan). Microgel suspensions (1–2 mL)
were immersed in physiological saline (10 mL) and vortexed to
separate individual beads. Optical images were obtained using
a digital camera and further analyzed using the instrument
software (EZ CSI version 3.8, Nikon).
Scanning Electronic Microscopy (SEM)
The bead microstructure was characterized using a bench-
top scanning electron microscope (JCM-6000 NeoScope, JEOL,
Tokyo, Japan). To prepare the samples prior to analysis, alginate,
and chitosan-coated alginate beads were freeze-dried and sputter-
coated with gold (10 nm) before loading onto the microscope.
Images of the microgels were documented in representative
fields.
Electrical Properties
The surface potential (ζ-potential) of alginate and chitosan-
coated alginate microgels was evaluated by electrophoretic
light scattering (Zetasizer Nano ZS, Malvern Instruments,
Worcestershire, UK). For each sample, refrigerated microgels
(1–2 mL) were suspended in distilled water (10 mL) and vortexed
to separate the beads. Samples were then loaded into the
measurement cells and analyzed.
Modeled Long-term Storage Conditions
of Encapsulated Bifidobacteria
Total cell counts of free and encapsulated bifidobacteria were
determined by a modified drop plate method as previously
described (Herigstad et al., 2001). Briefly, 10 drops (10 µL) of a
dilution within a series (100–107) were deposited on MRS agar
plates and counted after incubation under anaerobic conditions
at 37◦C.
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To determine viable counts of the encapsulated bacteria, beads
(1 mL) were re-suspended in 10% sodium citrate dihydrate
solution (9 mL) followed by vortexing. The number of released
cells was determined by plate count using MRS agar, dilutions
of dissolved beads (10−1–10−7) were plated in duplicate and
incubated at 37◦C anaerobically for 40 h. For lower viability
samples later, beads (2 mL) were re-suspended in 10% sodium
citrate dihydrate solution (2 mL) instead, and dilutions (100–
10−3) were plated as before. Samples were taken over a 4-week
period on days 0 (initial), 1, 3, 5, 7, 10, 14, 21, and 28. Day 24 was
also plated for free cell samples.
In Vitro Simulated Digestion of Alginate
and Chitosan-Coated Alginate
Microbeads
Fluids used in in vitro modeling of digestion were prepared
based on the method described by Li et al. (2011). One liter
of modeled saliva stock solution was prepared with ammonium
nitrate (0.328 g), potassium chloride (0.202 g), potassium citrate
(0.308 g), potassium phosphate (0.636 g), sodium chloride
(1.594 g), sodium DL-lactate (0.146 g), urea (0.198 g), and uric
acid sodium salt (0.021 g) in distilled water. The stock solution
was then filter-sterilized. The day before digestion experiments
were carried out, the salivary phase was prepared by adding
porcine gastric mucin type II (2.4 g) to saliva stock solution
(80 mL). The solution was stirred overnight at room temperature
to completely dissolve the powder.
One liter of simulated gastric stock solution was prepared
by adding sodium chloride (2 g) and 6 M hydrochloric acid
(7 mL) to distilled water and filter sterilizing. The simulated
intestinal stock solution (500 ml) was prepared by adding calcium
chloride hexahydrate (27.38 g) and sodium chloride (109.685 g)
to distilled water and autoclaved. Pepsin extracted from porcine
gastric mucosa (0.32 g) was then added to gastric stock solution
(100 mL).
The day before digestion experiments were carried out,
porcine bile extract (0.75 g) was added to PBS solution (14 mL)
for the modeled intestinal phase. The solution was stirred
overnight at room temperature to completely dissolve the
powder. Lipase from porcine pancreas type II (0.24 g) was
dissolved in PBS solution (10 mL); the solution (5 mL) was then
added with bile salt solution (7 mL) and intestinal stock solution
(33 mL).
Free and encapsulated bifidobacteria cells were separately
added to simulated saliva fluids (22 mL, pH adjusted to 6.7–
6.8), simulated gastric fluids (45 mL, pH adjusted to 2.5–2.6) or
simulated intestinal fluids (45 mL, pH adjusted to 7.0–7.2) and
stored in a shaking incubator (MaxQ 6000, Thermo Scientific,
Waltham, MA, USA) set at 37◦C with a shaking speed of 110 rpm
(Supplementary Figure S1). Dilutions (100–105) were plated on
MRS agar for initial, 5, 10, 15, or 30 min exposure and incubated
anaerobically for at least 48 h.
Statistical Analysis
The mean of two or three individual determinations was used
to calculate particle size, ζ-potential. The mean of 10 replicate
drops was used to calculate cell counts. Analysis of variance
(ANOVA) followed by Tukey honest significant difference test
was use to analyze all data and compare individual means. This
was performed using statistical software (GraphPad Prism 6,
GraphPad Software, La Jolla, CA, USA).
RESULTS
Particle Size Analysis of Alginate and
Chitosan-Coated Alginate Microgels
Light scattering was used to determine the mean particle
diameter of the different microgel samples (Table 2). The mean
particle sizes of alginate beads containing similar strains were
similar, ranging from 135 to 185 µm (D [3,2]) for encapsulated
B. infantis strains and 149–216 µm (D [3,2]) for encapsulated
B. longum strains. The chitosan-coated alginate beads were
significantly larger compared than the alginate beads, ranging
from 191 to 292 µm (D [3,2]). This increase in particle size
may have been because of the additional coating formed by
the alginate molecules, or because of some aggregation of the
microgels. Microgel aggregation may have occurred due to
bridging flocculation, which is the ability of the chitosan cation
to adsorb to the surfaces of two or more anionic alginate beads.
Additional information regarding the structural configuration of
the microgels was therefore obtained through microscopy.
Optical Microscopy of Alginate and
Chitosan-Coated Alginate Microbeads
The structures of samples containing free cells or bacterial-
loaded microgels were determined using optical microscopy
TABLE 2 | Volume-based (D [4,3]) and surface-based (D [3,2]) mean
particle diameters measured by static light scattering alginate and
chitosan-coated alginate beads with strains of bifidobacteria.
Beads µm
D [4,3] D [3,2]
Alg.
Subsp. infantis UMA 298 233 ± 4ab 167 ± 6abc
UMA 299 230 ± 3ab 162 ± 3b
UMA 300 251 ± 6a 185 ± 12cd
UMA 305 211 ± 4b 135 ± 2e
Subsp. longum UMA 306 247 ± 13ac 164 ± 4ab
UMA 318 228 ± 11ab 149 ± 13abe
UMA 401 277 ± 4cd 216 ± 3f
UMA 402 287 ± 13de 195 ± 3dfg
Chit.-alg.
Subsp. infantis UMA 299 327 ± 2fg 292 ± 3h
UMA 300 344 ± 14f 237 ± 3i
Subsp. longum UMA 401 310 ± 20eg 213 ± 4f
UMA 402 315 ± 26efg 191 ± 11g
Values are shown as average particle size ± standard deviation. Values followed by
the same letters in the same column are not significantly different (p > 0.05) from
each other.
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immediately after encapsulation (Figure 1). Free cells appeared
rod-shaped as expected for bifidobacteria (Figures 1A,D).
The unfilled alginate and chitosan-coated alginate microgels
were similar in morphology, although the individual coated
alginate beads did appear larger than the uncoated ones, which
is consistent with the particle size analysis (Figures 1C,F).
Encapsulated bifidobacteria were clearly visualized within
the microgels for both alginate and chitosan-coated alginate
microgels (Figures 1E,F). The bifidobacterial-loaded alginate and
chitosan-coated alginate beads had a similar external appearance
as the equivalent unloaded beads. The microgels were generally
spherical with diameters around 100–300 µm for all samples.
Scanning Electron Microscopy
Scanning electron microscopy (SEM) was used to inspect the
structure of the alginate and chitosan-coated alginate beads
(Figure 2). Freeze-dried microgels were uniform in size and
shape. However, the surfaces of the microgels observed by SEM
appeared wrinkled, whereas they presented as smooth when
observed by optical microscopy. This is likely due to sublimation
of water originally trapped within the hydrogel matrix, as has
been described previously (Yeung et al., 2016). The chitosan-
coated alginate beads appeared to be more irregular in shape
compared to alginate beads. Qualitatively, the alginate beads had
smoother wrinkles and microstructures, whereas the chitosan-
coated beads exhibited sharp jagged edges. This observation
suggests that the chitosan layer has been successfully deposited
onto the external surfaces of the alginate microgels.
Zeta Potential Analysis of
Microencapsulated Bifidobacteria
Electrophoretic light scattering was used to evaluate the electrical
characteristics of the microgels (Table 3). The ζ-potentials of all
the alginate beads were negative, ranging from −4.2 to −9.4 mV
for B. infantis and −2.6 to −4.4 mV for B. longum as predicted
with this coating. In contrast, all chitosan-coated alginate bead
samples had positive surface potentials ranging from +9.9 to
+14.9 mV for B. infantis and +0.8 to +9.0 mV for B. longum.
These results indicate that the cationic chitosan molecules formed
a secondary shell around the anionic calcium alginate beads.
Survival of Bifidobacterial Strains during
Long-term Storage
Non-encapsulated Bifidobacterial Cells
The viability of four B. longum and four B. infantis strains that
were not encapsulated was determined during 5 weeks of storage
FIGURE 1 | Optical microscope images of (A) Bifidobacterium longum subsp. infantis UMA 300 (20×), (B) unfilled alginate bead (20×), (C) filled
alginate bead with B. longum subsp. longum UMA 306 (20×), (D) B. longum subsp. longum UMA 318 (20×), (E) unfilled chitosan-coated alginate bead
(20×), (F) filled chitosan-coated alginate bead with B. longum subsp. infantis UMA 299 (20×). Scale bars represent 100 µm.
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FIGURE 2 | Scanning electron micrographs of (A) B. longum subsp. infantis UMA299, (B) unfilled alginate bead, (C) unfilled chitosan-coated alginate
bead, (D) B. longum subsp. longum UMA 306, (E) alginate bead containing B. longum subsp. longum UMA 401, (F) chitosan-coated alginate bead
containing B. longum subsp. longum UMA 300. Samples were dried before sputter-coating with gold. SEM was set at high-vacuum, 10 kV.
(Figure 3A; Supplementary Table S1). As expected, there was a
decrease in the viability of the bifidobacteria evaluated, but the
rate of the decrease was strain dependent. A sharp decrease in
viability was observed for B. infantis UMA318 and B. longum
UMA401, diminishing by 9–10 log CFU over the course of a week
under aerobic conditions. B. infantis UMA 300 and B. infantis
UMA 305 remained viable for slightly longer, with a 10-log
reduction observed within 10 days. Whereas, B. infantis UMA
298 and B. infantis 306 exhibited a 9–10 log decrease over 2 weeks
of storage. Interestingly, B. infantis UMA 299 and B. longum
UMA 402 survived the longest, as viable cell counts diminished
by 7–8 logs over 3 weeks before decreasing to undetectable
levels.
Encapsulated Bifidobacterial Cells
Viability following encapsulation was determined for all
eight bifidobacterial strains (Figure 3B; Supplementary Table
S2). There were distinct differences between the effects of
encapsulation depending on strain type. The cell viability of
B. infantis UMA 298, B. infantis UMA 305, and B. longum UMA
318 stains rapidly decreased and were undetectable after 3 days.
Unexpectedly, B. infantis UMA 298 and B. infantis UMA 305 in
alginate were inactivated faster than the corresponding free cells,
TABLE 3 | Zeta potential of alginate and chitosan-coated alginate beads
with strains of bifidobacteria.
Beads mV
Alg.
Subsp. infantis UMA 298 −5.23 ± 2.06ab
UMA 299 −9.42 ± 2.54a
UMA 300 −8.73 ± 4.88a
UMA 305 −4.15 ± 1.17ab
Subsp. longum UMA 306 −3.14 ± 2.24ab
UMA 318 −2.60 ± 0.04ab
UMA 401 −4.38 ± 0.64ab
UMA 402 −4.28 ± 1.12ab
Chit.-alg.
Subsp. infantis UMA 299 9.92 ± 3.92c
UMA 300 14.87 ± 4.26c
Subsp. longum UMA 401 0.79 ± 2.53bd
UMA 402 9.03 ± 4.90cd
Values are shown as average ζ-potential ± standard deviation. Values followed by
the same letters are not significantly different (p > 0.05) from each other.
being undetectable after 24 and 10 days, respectively. Viability of
the encapsulated B. longum UMA 318 was identical to that of free
cells. B. infantis UMA 300, B. longum UMA 306, B. longum 401,
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FIGURE 3 | Survival of (A) free B. longum cells, (B) B. longum cells in calcium alginate microbeads, (C) B. longum cells in chitosan-coated alginate
microbeads in wet refrigerated storage over time. Counts based on samples drop-plated on MRS agar and incubated at 37◦C anaerobically. Error bars
indicate the standard error of replicate counts (n = 10).
and B. longum 402 maintained viable populations that decreased
by 3–4 log CFU after 10 days of storage before rapidly decreasing
to zero. Encapsulated B. infantis UMA 300 survived 3 days
longer than corresponding free cells; encapsulated B. longum
UMA 401 lasted a week longer than free cells. Encapsulated
B. longum UMA 306 survived similarly to free cells, and
encapsulated B. longum UMA 402 survived over a week shorter
than corresponding free cells. Interestingly, B. infantis UMA 299
viability was enhanced as it experienced a 5 log CFU reduction
in 3 weeks compared to an 8 log CFU reduction during this
time for the non-encapsulated cells. Thus, encapsulating with
alginate extended cell viability of B. infantis UMA 299 and 300
by a few days, and extended viability of B. longum UMA 401 cells
by a week. Encapsulating other B. infantis and B. longum strains
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did not appear to extend viability over the storage conditions
used.
Two strains each of B. infantis (UMA 299 and 300) and
B. longum (UMA 401 and 402) were encapsulated in a secondary
coating of chitosan applied to the alginate bead core and
submitted to testing over time (Figure 3C; Supplementary Table
S3). B. longum UMA 401 and 402 both decreased 3–4 log within
3 days, and fell to undetectable levels by 2 weeks. Viability
of B. infantis UMA 299 and B. infantis UMA 300 decreased
only 2 logs in 5 days, before falling to undetectable levels after
2 weeks. Encapsulating B. infantis UMA 299, B. infantis UMA
300, and B. longum UMA 401 cells in chitosan-coated alginate
beads did not appear to extend viability compared with uncoated
alginate microbeads. B. longum UMA 402 cells in chitosan-coated
alginate decreased 2.4 log CFU, whereas B. longum UMA 402
cells in alginate alone decreased 7.2 log CFU, between day 3 and
day 14. Hence, encapsulating B. longum UMA 402 in chitosan-
coated alginate extended detectible viability 4 days more than
encapsulating B. longum UMA 402 in alginate alone.
Survival of Encapsulated Cells during
Simulated Digestion
Free and bifidobacterial cells encapsulated in chitosan-coated
alginate beads were subjected to simulated digestion in a GIT
model as previously described (Li et al., 2011). Free B. infantis
UMA 299 and cells encapsulated chitosan-coated alginate were
immersed separately in simulated salivary, gastric, and intestinal
phases and assessed over time for cell viability (Table 4).
The strain was selected based on its high viability during
storage in free and encapsulated forms (Table 3; Supplementary
Tables S1–S3). The bacteria appeared to be relatively stable
within simulated saliva fluids, as less than a 1 log CFU
reduction was experienced in 30 min of exposure regardless
of encapsulation. The model salivary juice did not greatly
inhibit cell viability in general, as less than one log CFU
reduction was experienced in 30 min of exposure regardless of
encapsulation. However, microencapsulation provided enhanced
protection for UMA299 by shielding the strain from the low pH
of the gastric phase. Encapsulated cells decreased by 1.4 logs
CFU, whereas untreated cells decreased by 2.7 logs following
exposure to pH 2.5 conditions (5 min). This indicates a
significant, albeit fleeting protection afforded to the encapsulated
cells as viability was abrogated after 10 min of exposure to
the gastric phase. Similarly, UMA299 cell viability was not
detectible after 5 min of exposure to the intestinal phase.
B. longum UMA 402 encapsulated in chitosan-coated alginate
was also subjected to simulated digestion in preliminary tests
(data not shown). As with B. infantis, cell viability remained
stable in the modeled salivary phase, but underwent a 6-
log reduction after only a few minutes exposure to gastric
phase (pH 2.5).
DISCUSSION
Initially, chitosan-coating of alginate beads was postulated to
enhance the viability of encapsulated probiotics by reducing their
exposure to environmental stresses during storage and within
the GIT (Kamalian et al., 2014). Accordingly, the influence of
encapsulation on a panel of B. longum strains to assess differential
viability was systematically studied. The calcium alginate beads
formed using an injection–gelation method were roughly
spherical in shape, negatively charged, and had dimensions
around 130–220 µm. Coating the alginate beads with chitosan
caused a small increase in their size and changed their charge
from negative to positive. Optical microscopy (Figures 1C,F)
confirmed that the bifidobacteria were immobilized within the
hydrogel beads, which is consistent with previous encapsulation
studies (Hansen et al., 2002; Fareez et al., 2015; Yeung et al.,
2016).
Interestingly, encapsulation of bifidobacteria in chitosan-
coated alginate beads led to decreased improvement in their
storage or gastrointestinal stability compared with cells in
alginate beads. One possible explanation for this observation
is that the alginate hydrogel used had relatively large pores,
and so small molecules, such as oxygen, acids, bile salts, or
digestive enzymes, could easily diffuse into the microgels and
inactivate the encapsulated bacteria (McClements, 2015). These
results suggest that a simple secondary layer of chitosan alone
TABLE 4 | Simulated digestion of free and encapsulated B. longum subsp. infantis UMA 299 in three separate stages.
log CFU
Time (minutes) Free Encapsulated
Saliva Gastric Intestinal Saliva Gastric Intestinal
pH 6.74 2.53 7.04 6.78 2.57 7.12
0 9.63 ± 0.07aA 9.63 ± 0.07aA 9.63 ± 0.07aA 8.40 ± 0.84abB 8.40 ± 0.84aB 8.40 ± 0.84aB
5 9.17 ± 0.06a 6.99 ± 0.03b ND 8.10 ± 0.05a 6.90 ± 0.04a ND
10 9.28 ± 0.09a ND ND 7.89 ± 0.07a ND ND
15 9.14 ± 0.06a ND ND 6.42 ± 1.07b ND ND
30 9.01 ± 0.06a ND ND 8.14 ± 0.040a ND ND
Counts based on samples drop-plated on MRS agar and incubated at 37◦C anaerobically. Values are shown as mean cell number ± standard error of replicate counts
(n = 10). Means within each column followed by the same lowercase letters are not significantly different (p > 0.05) from each other. Means within each row followed by
the same uppercase letters are not significantly different (p > 0.05) from each other.
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will not fully protect encapsulated bifidobacteria, and that further
optimization is required to engineer more effective delivery
systems. Previous studies have shown that alginate has a prebiotic
effect on bifidobacteria, which might account for its ability
to enhanced viability, potentially through a non-encapsulation
mechanism (Wang et al., 2006; Ramnani et al., 2012). In
future studies, it may be useful to examine the influence of
different biopolymer materials and methods on the ability of
microgels to enhance probiotic viability. As an example, the
hydrogel pore size may be decreased to limit molecular diffusion,
with the addition of anti-oxidants to limit oxidation reactions
and prebiotics to stimulate probiotic growth in the colon.
Since bifidobacteria ferment oligosaccharides within the gut, a
synbiotic approach that integrates prebiotic substrates including
plant or milk oligosaccharides may advance bifidobacterial-
based delivery (Sela, 2011). Alternatively, judicious selection of
strain selection that are resistant to acids, bile salts, or digestive
enzymes may enhance the delivery scheme. However, previous
studies indicate that most bifidobacteria strains typically exhibit
a significant decrease in survival around pH 4 which would
necessitate shielding from gastric conditions (Sun and Griffiths,
2000).
Bifidobacteria have been exposed to simulated digestive fluids
in previously conducted studies (O’Riordan et al., 2001; Hansen
et al., 2002; Kamalian et al., 2014). Although specific strains tested
and experimental schemes vary between studies. Hansen et al.
(2002) encapsulated several bifidobacterial strains in microgels
formed by an emulsion-templating method, and then exposed
them to simulated gastric and small intestinal fluids. In this
study, B. infantis and B. longum strains showed a 4–6 log
CFU/mL decrease between exposure to gastric fluids set at
pH 6.0 and pH 2.0 for 2 h, and 3–5 log CFU/mL reduction
between exposure to intestinal fluid containing 0 and 1% bile
for 24 h. Hansen et al. (2002) also encapsulated B. longum
experienced a 5-log CFU/mL reduction after 30 min exposure
to gastric juice (pH 2.0). In the study herein, B. infantis UMA
299 encapsulated in chitosan-coated alginate underwent an 8-
log reduction in a 10-min exposure to gastric fluid (pH 2.6),
and an 8-log reduction in 5 min exposure to intestinal fluid
(Figure 3C; Supplementary Table S3). This study included 0.75%
bile extract, pepsin, and lipases in the gastric and intestinal
fluids for the purpose of simulating the harsh conditions of
the human GIT. The bifidobacterial general stress response has
been studied (Sánchez et al., 2007; Zomer et al., 2009). As with
the phylogenetically dissimilar lactic acid bacteria, bifidobacteria
employ ATPases to pump protons from the cell when exposed
to acidic conditions (Matsumoto et al., 2004; Ventura et al.,
2004). In addition, when exposed to bile during gastrointestinal
transit, certain bifidobacterial strains deploy bile salt hydrolase
to promote cell survival in the small intestine (Ruiz et al.,
2014).
In an additional study, an emulsion encapsulation method
was performed on B. pseudocatenulatum G4 in chitosan-coated
alginate and exposed to gastric conditions (pH 1.5) for 2 h
followed by intestinal phase for 5 h (Kamalian et al., 2014).
The encapsulated B. pseudocatenulatum experienced a 4-log
reduction when encapsulated in alginate and a 2-log reduction
in chitosan-coated alginate, relative to the 5-log reduction in
the control. However, this was accomplished in the absence of
digestive enzymes or bile salts in simulated gastric and intestinal
fluids that would present additional hurdles to the bifidobacterial
cells. O’Riordan et al. (2001) studied spray-dried Bifidobacterium
spp. PL1 in starch and subjected the resultant granules to
simulated digestion. After 3 h of exposure to buffer with pH 2.8,
they were unable to detect viable cells as well as other sampling
points in between 0 and 3 h. This is consistent with the results
presented in this study.
In summary, bifidobacterial viability following encapsulation
varied between subspecies as well as strains. This suggests that
there is a range of genotypic and phenotypic factors contributing
to stress responses that promote enhanced viability. Further
functional genomic analysis of encapsulated probiotic organisms
can aid in matching strains with the particular encapsulation
process to optimize cell integrity during storage. Moreover,
similar approaches may be used in selecting ideal delivery vehicles
to shield bifidobacteria during GIT transit to arrive intact and
metabolically poised to exert beneficial activities in the distal
colon. Subsequent formulations may optimize delivery vehicles
by incorporating antioxidants and cryoprotectants within the
encapsulation gel matrix to preserve bifidobacterial cell viability.
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